The document summarizes a study that analyzed 612 Australian television news stories about alcohol from 2005 to 2010. The majority of stories (69%) were triggered by a newsworthy incident or research findings and focused on alcohol-related harms (30%) and binge drinking (19%). Most stories (75%) mentioned health effects of alcohol but focused mainly on short-term consequences. While 63% of stories mentioned an alcohol policy, no single policy received more than 10% coverage. The most common sources featured were public health professionals (50%), community members (28%), and government representatives (24%).
Editorial: Evidence based policy or policy based evidence? by Michael MarmotJim Bloyd, DrPH, MPH
A simple prescription would be to review the scientific evidence of what would make a difference, formulate policies, and implement them—evidence based policy making. Unfor- tunately this simple prescription, applied to real life, is simplistic. The relation between science and policy is more complicated. Scientific findings do not fall on blank minds that get made up as a result. Science engages with busy minds that have strong views about how things are and ought to be.
This document discusses progress toward ending the tobacco epidemic in the United States. It outlines key challenges like the health burden of tobacco use and industry marketing. It also highlights recent legislative actions that provide tools to reduce tobacco use, like increasing cigarette taxes, granting FDA regulatory authority, and expanding insurance coverage for cessation services. The document presents an HHS strategic plan to achieve Healthy People 2020 tobacco control objectives through actions like coordinating federal efforts, supporting state programs, changing social norms, and advancing research.
05-09 STATEMENT OF POLICY Syringe Services Progra.docxsmithhedwards48727
05-09
STATEMENT OF POLICY
Syringe Services Programs
Policy
The National Association of County and City Health Officials (NACCHO) supports a comprehensive, evidence-
based approach to syringe services programs, also known as syringe or needle exchange programs, in order to
support the health of people who inject drugs and to curb transmission of HIV, viral hepatitis, and other blood-
borne diseases. NACCHO urges state and local policy makers to do the following:
• Support syringe services program development and operation in accordance with the peer-reviewed
evidence base, best practices, and local health department and other expert recommendations;
• Remove legal barriers to accessing and safely disposing sterile needles, syringes, and other injecting
equipment;
• Modify state and local statutes to permit over-the-counter pharmacy sales and purchase of syringes;
• Revise paraphernalia laws to decriminalize syringe possession;
• Increase the availability of drug treatment and overdose prevention, including Medication-Assisted
Treatment and naloxone training and distribution;
• Ensure education of law enforcement, criminal justice personnel, health department staff, healthcare
providers, pharmacists, and other relevant professional and community partners regarding the benefit of
syringe services programs, as well as other harm reduction strategies, and relevant laws, policies, and
processes; and
• Assure adequate resources to support health department surveillance, program planning, and program
evaluation capacity to assess disease and risk behavior trends and the impact of syringe services
programs, as well as other disease prevention and health promotion interventions for persons who inject
drugs, on local health outcomes.
Furthermore, NACCHO urges Congress to remove the ban on the use of federal funds to support syringe
services programs.
Justification
Injection drug use is a major route of transmission for HIV, viral hepatitis, and other blood-borne pathogens.
Over the past 25 years, syringe services programs have proven to be highly effective at reducing HIV
transmission among people who inject drugs and are an essential strategy to prevent hepatitis C virus (HCV)
infection. In addition to providing sterile syringes and other injecting equipment, many syringe service
programs also provide medical and social services, including HIV and viral hepatitis testing, overdose
prevention training, referrals to social services and housing, and linkages to medical care, mental health care,
and substance use treatment, to individuals who are not often served by traditional healthcare providers.1
2
In the United States, HIV incidence among people who inject drugs declined by approximately 80% from 1988
to 2006 following the adoption of syringe service programs in a number of states.2 Despite that overall decline,
people who inject drugs continue to represent a substantial proportion .
https://www.youtube.com/watch?v=d4MWYifumqI
http://www.readwritethink.org/classroom-resources/lesson-plans/directed-listening-thinking-activity-850.html
05-09
STATEMENT OF POLICY
Syringe Services Programs
Policy
The National Association of County and City Health Officials (NACCHO) supports a comprehensive, evidence-
based approach to syringe services programs, also known as syringe or needle exchange programs, in order to
support the health of people who inject drugs and to curb transmission of HIV, viral hepatitis, and other blood-
borne diseases. NACCHO urges state and local policy makers to do the following:
• Support syringe services program development and operation in accordance with the peer-reviewed
evidence base, best practices, and local health department and other expert recommendations;
• Remove legal barriers to accessing and safely disposing sterile needles, syringes, and other injecting
equipment;
• Modify state and local statutes to permit over-the-counter pharmacy sales and purchase of syringes;
• Revise paraphernalia laws to decriminalize syringe possession;
• Increase the availability of drug treatment and overdose prevention, including Medication-Assisted
Treatment and naloxone training and distribution;
• Ensure education of law enforcement, criminal justice personnel, health department staff, healthcare
providers, pharmacists, and other relevant professional and community partners regarding the benefit of
syringe services programs, as well as other harm reduction strategies, and relevant laws, policies, and
processes; and
• Assure adequate resources to support health department surveillance, program planning, and program
evaluation capacity to assess disease and risk behavior trends and the impact of syringe services
programs, as well as other disease prevention and health promotion interventions for persons who inject
drugs, on local health outcomes.
Furthermore, NACCHO urges Congress to remove the ban on the use of federal funds to support syringe
services programs.
Justification
Injection drug use is a major route of transmission for HIV, viral hepatitis, and other blood-borne pathogens.
Over the past 25 years, syringe services programs have proven to be highly effective at reducing HIV
transmission among people who inject drugs and are an essential strategy to prevent hepatitis C virus (HCV)
infection. In addition to providing sterile syringes and other injecting equipment, many syringe service
programs also provide medical and social services, including HIV and viral hepatitis testing, overdose
prevention training, referrals to social services and housing, and linkages to medical care, mental health care,
and substance use treatment, to individuals who are not often served by traditional healthcare providers.1
2
In the United States, HIV incidence among people who inject drugs declined by approximately 80% from 1988
to 2006 following the ado ...
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...Jim Bloyd, DrPH, MPH
"The creation of meaning may be an unfamiliar role for public health, but one whose import comes into sharp relief when we recognize the inevitability of the political at the heart of what we do."
Where there is no vision the people perishJohn Middleton
A presentation of the work of the Faculty of public Health and the place of rights, values, ethics and law in improving the health of the public. 181102 middletonj scottish conference final
This document discusses tobacco control and prevention policies recommended by the American College of Physicians. It provides background on the health and economic impacts of tobacco use. Key points include:
- Tobacco use is the leading preventable cause of death in the US. Comprehensive tobacco control programs are needed to reduce smoking rates.
- The FDA was given authority in 2009 to regulate tobacco, but regulation alone is not enough. States must fund tobacco control efforts and increase tobacco taxes.
- Smokeless tobacco and cigars also harm health. Secondhand smoke exposure causes illness and death in nonsmokers.
This document discusses harm reduction strategies for cannabis use. It begins by providing background on cannabis use prevalence and the polarized debates around the drug. It then reviews the major health harms from acute and chronic cannabis use based on evidence, including negative psychological effects, cognitive impairment, and respiratory issues. The document aims to promote discussion of harm reduction for cannabis users while not taking a position on drug policy. It argues for a broad approach to reducing cannabis-related harm at both individual and community levels.
Editorial: Evidence based policy or policy based evidence? by Michael MarmotJim Bloyd, DrPH, MPH
A simple prescription would be to review the scientific evidence of what would make a difference, formulate policies, and implement them—evidence based policy making. Unfor- tunately this simple prescription, applied to real life, is simplistic. The relation between science and policy is more complicated. Scientific findings do not fall on blank minds that get made up as a result. Science engages with busy minds that have strong views about how things are and ought to be.
This document discusses progress toward ending the tobacco epidemic in the United States. It outlines key challenges like the health burden of tobacco use and industry marketing. It also highlights recent legislative actions that provide tools to reduce tobacco use, like increasing cigarette taxes, granting FDA regulatory authority, and expanding insurance coverage for cessation services. The document presents an HHS strategic plan to achieve Healthy People 2020 tobacco control objectives through actions like coordinating federal efforts, supporting state programs, changing social norms, and advancing research.
05-09 STATEMENT OF POLICY Syringe Services Progra.docxsmithhedwards48727
05-09
STATEMENT OF POLICY
Syringe Services Programs
Policy
The National Association of County and City Health Officials (NACCHO) supports a comprehensive, evidence-
based approach to syringe services programs, also known as syringe or needle exchange programs, in order to
support the health of people who inject drugs and to curb transmission of HIV, viral hepatitis, and other blood-
borne diseases. NACCHO urges state and local policy makers to do the following:
• Support syringe services program development and operation in accordance with the peer-reviewed
evidence base, best practices, and local health department and other expert recommendations;
• Remove legal barriers to accessing and safely disposing sterile needles, syringes, and other injecting
equipment;
• Modify state and local statutes to permit over-the-counter pharmacy sales and purchase of syringes;
• Revise paraphernalia laws to decriminalize syringe possession;
• Increase the availability of drug treatment and overdose prevention, including Medication-Assisted
Treatment and naloxone training and distribution;
• Ensure education of law enforcement, criminal justice personnel, health department staff, healthcare
providers, pharmacists, and other relevant professional and community partners regarding the benefit of
syringe services programs, as well as other harm reduction strategies, and relevant laws, policies, and
processes; and
• Assure adequate resources to support health department surveillance, program planning, and program
evaluation capacity to assess disease and risk behavior trends and the impact of syringe services
programs, as well as other disease prevention and health promotion interventions for persons who inject
drugs, on local health outcomes.
Furthermore, NACCHO urges Congress to remove the ban on the use of federal funds to support syringe
services programs.
Justification
Injection drug use is a major route of transmission for HIV, viral hepatitis, and other blood-borne pathogens.
Over the past 25 years, syringe services programs have proven to be highly effective at reducing HIV
transmission among people who inject drugs and are an essential strategy to prevent hepatitis C virus (HCV)
infection. In addition to providing sterile syringes and other injecting equipment, many syringe service
programs also provide medical and social services, including HIV and viral hepatitis testing, overdose
prevention training, referrals to social services and housing, and linkages to medical care, mental health care,
and substance use treatment, to individuals who are not often served by traditional healthcare providers.1
2
In the United States, HIV incidence among people who inject drugs declined by approximately 80% from 1988
to 2006 following the adoption of syringe service programs in a number of states.2 Despite that overall decline,
people who inject drugs continue to represent a substantial proportion .
https://www.youtube.com/watch?v=d4MWYifumqI
http://www.readwritethink.org/classroom-resources/lesson-plans/directed-listening-thinking-activity-850.html
05-09
STATEMENT OF POLICY
Syringe Services Programs
Policy
The National Association of County and City Health Officials (NACCHO) supports a comprehensive, evidence-
based approach to syringe services programs, also known as syringe or needle exchange programs, in order to
support the health of people who inject drugs and to curb transmission of HIV, viral hepatitis, and other blood-
borne diseases. NACCHO urges state and local policy makers to do the following:
• Support syringe services program development and operation in accordance with the peer-reviewed
evidence base, best practices, and local health department and other expert recommendations;
• Remove legal barriers to accessing and safely disposing sterile needles, syringes, and other injecting
equipment;
• Modify state and local statutes to permit over-the-counter pharmacy sales and purchase of syringes;
• Revise paraphernalia laws to decriminalize syringe possession;
• Increase the availability of drug treatment and overdose prevention, including Medication-Assisted
Treatment and naloxone training and distribution;
• Ensure education of law enforcement, criminal justice personnel, health department staff, healthcare
providers, pharmacists, and other relevant professional and community partners regarding the benefit of
syringe services programs, as well as other harm reduction strategies, and relevant laws, policies, and
processes; and
• Assure adequate resources to support health department surveillance, program planning, and program
evaluation capacity to assess disease and risk behavior trends and the impact of syringe services
programs, as well as other disease prevention and health promotion interventions for persons who inject
drugs, on local health outcomes.
Furthermore, NACCHO urges Congress to remove the ban on the use of federal funds to support syringe
services programs.
Justification
Injection drug use is a major route of transmission for HIV, viral hepatitis, and other blood-borne pathogens.
Over the past 25 years, syringe services programs have proven to be highly effective at reducing HIV
transmission among people who inject drugs and are an essential strategy to prevent hepatitis C virus (HCV)
infection. In addition to providing sterile syringes and other injecting equipment, many syringe service
programs also provide medical and social services, including HIV and viral hepatitis testing, overdose
prevention training, referrals to social services and housing, and linkages to medical care, mental health care,
and substance use treatment, to individuals who are not often served by traditional healthcare providers.1
2
In the United States, HIV incidence among people who inject drugs declined by approximately 80% from 1988
to 2006 following the ado ...
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...Jim Bloyd, DrPH, MPH
"The creation of meaning may be an unfamiliar role for public health, but one whose import comes into sharp relief when we recognize the inevitability of the political at the heart of what we do."
Where there is no vision the people perishJohn Middleton
A presentation of the work of the Faculty of public Health and the place of rights, values, ethics and law in improving the health of the public. 181102 middletonj scottish conference final
This document discusses tobacco control and prevention policies recommended by the American College of Physicians. It provides background on the health and economic impacts of tobacco use. Key points include:
- Tobacco use is the leading preventable cause of death in the US. Comprehensive tobacco control programs are needed to reduce smoking rates.
- The FDA was given authority in 2009 to regulate tobacco, but regulation alone is not enough. States must fund tobacco control efforts and increase tobacco taxes.
- Smokeless tobacco and cigars also harm health. Secondhand smoke exposure causes illness and death in nonsmokers.
This document discusses harm reduction strategies for cannabis use. It begins by providing background on cannabis use prevalence and the polarized debates around the drug. It then reviews the major health harms from acute and chronic cannabis use based on evidence, including negative psychological effects, cognitive impairment, and respiratory issues. The document aims to promote discussion of harm reduction for cannabis users while not taking a position on drug policy. It argues for a broad approach to reducing cannabis-related harm at both individual and community levels.
The document discusses the health promotion activity of encouraging smoking cessation. It assesses the health needs, outlines the target group as smokers, and chooses an educational approach to provide information about the benefits of quitting smoking. The aims are to increase awareness of benefits, diseases caused by smoking, and where to get help. Process evaluation determined the information provided addressed different learning styles and was effective at engaging the target group.
Major tobacco-related-events-in-the-united-statesGeorgi Daskalov
This document provides a summary of major tobacco-related events in the United States from World War II to the 1980s. It outlines key milestones such as the first studies linking smoking to cancer in the 1950s, the 1964 Surgeon General's report that concluded smoking causes disease, restrictions on tobacco advertising and the introduction of warning labels on cigarette packs. It also discusses tobacco industry efforts to downplay health risks and market "safer" cigarettes while nicotine levels increased. The summary covers events that increased public awareness of tobacco's dangers and early policies to regulate tobacco use.
Reducing Tobacco Use Among Adolescents Using Social Cognitive Theory and Soci...Shauna Ayres, MPH, CHES
This document discusses reducing tobacco use among adolescents using Social Cognitive Theory (SCT) and Social Network Theory (SNT). It summarizes key aspects of SCT, including its focus on personal, behavioral, and environmental factors that influence health behaviors. Studies discussed found targeting self-efficacy, normative beliefs, and intentions through programs and policies were effective in preventing or reducing tobacco use. The document suggests using a multi-strategy approach incorporating several SCT constructs is most effective for interventions.
Analysis of alcohol industry submissions against marketing regulationBARRY STANLEY 2 fasd
The document analyzes submissions from the Australian alcohol industry in response to a review of alcohol marketing regulations. It finds that the industry's submissions were a direct lobbying tactic aimed at influencing government policy. The submissions claimed that increased regulation is unnecessary, not backed by sufficient evidence, will have unintended negative consequences, and faces legal barriers. The industry emphasized notions of regulatory redundancy and insufficient evidence more than the tobacco industry did in similar submissions. This may reflect differences in how regulated the two industries are.
The document is the proceedings from the Australian Smoking Cessation Conference in 2013. It includes:
- An introduction welcoming attendees and emphasizing the theme of translating science into clinical practice.
- An overview by the Scientific Committee of the diverse and innovative abstracts presented on topics like tailored smoking cessation methods, novel uses of nicotine replacement therapy, and programs for vulnerable groups.
- Invited speaker abstracts on topics such as integrated treatment for substance users, a smoking cessation project for pregnant smokers, smoking rates and interventions for Aboriginal people, adolescent tobacco dependence and cessation approaches.
This case study analyzes the increasing levels of lead exposure among children in Flint, Michigan due to changes in the city's water source. The authors obtained data on blood lead levels in children from Hurley Medical Center and the Michigan Department of Health and Human Services. They also collected data on the costs of treating lead exposure and Aetna's financial reports from 2010-2014. Their analysis found trends linking higher lead exposure to the Flint water source and certain demographics. Their recommendations suggest adjusting Medicaid insurance plans to better manage costs of lead treatment and strategies for Aetna to decrease financial variability and increase coverage capabilities over a five-year period.
This document summarizes the report of the House of Commons Science and Technology Committee on the UK government's alcohol consumption guidelines. It provides background on the guidelines and their history. It discusses the evidence base for the guidelines and whether it has been adequately reviewed. It also examines how well the guidelines are communicated to and understood by the public, and compares the UK guidelines to those of other countries. The report concludes that the evidence base for using purported health benefits of alcohol as a basis for daily guidelines is weak. It finds public awareness of guidelines is high but understanding is lacking. It recommends the government establish a working group to thoroughly review the evidence and advise on updating the guidelines.
This document discusses key issues and recommendations for Canada to promote at the upcoming UNGASS on drugs and UN Commission on Narcotic Drugs meeting. It recommends that Canada: 1) Promote and implement a public health approach to drugs based on evidence and human rights, including harm reduction; 2) Support harm reduction as a key component of response to drugs; 3) Pursue and support decriminalization of drug possession for personal use as essential to a public health approach. A public health approach frames drug use as a health issue and prioritizes health and human rights over punishment. Harm reduction and decriminalization are seen as necessary for an effective public health-based system.
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...Global Bridges
Presentation by Eduardo Bianco, M.D., Framework Convention Alliance, Uruguay, at the Global Bridges Preconference at the 15th World Conference on Tobacco OR Health in Singapore.
The document discusses potential policy changes regarding drug laws. It argues that current drug policies are based on fear and criminalization rather than public health. It advocates treating drug use as a public health issue and moving away from prohibition towards prevention, harm reduction, and decriminalization. Evidence from places that have implemented these approaches, like Switzerland's heroin prescription program, shows decreases in illegal drug use and drug-related crime. However, drug legalization remains poorly perceived by the public who see drugs as threatening social values and youth.
This study examined the association between tobacco control policies and smoking prevalence, denormalization of smoking, and public support for tobacco control across European Union countries. The researchers found that countries with higher scores on the Tobacco Control Scale (measuring implementation of tobacco policies) had more smokers who reported quitting due to concerns about passive smoking harming others. This concern about passive smoking was also strongly correlated with greater public support for tobacco control policies. The results suggest that addressing concerns about passive smoking is important for advancing tobacco control measures and denormalizing tobacco use in Europe.
Australia's health system needs to better connect the dots in a number of areas. Our work looks at connections between Australian chronic disease targets and indicators, WHO targets and indicators, and national progress.
CDC Update: Joining Forces to Reduce Tobacco and Cancer Among Behavioral Heal...sfary
From the the first Annual National Conference on Tobacco and Behavioral Health, which occurred May 19-20, 2014 in Bethesda, MD and was hosted by the Central East Addiction Technology Transfer Center, a program of The Danya Institute. You can see videos from the conference on our website www.ceattc.org (go to “Tobacco and Behavioral Health Resources” under “Special Topics”).
Tim McAfee, MD, MPH, is Director of CDC’s Office on Smoking and Health (OSH) within the National Center for Chronic Disease Prevention and Health Promotion. He is responsible for providing leadership and direction for all scientific, policy, and programmatic issues related to tobacco control and prevention. Before ed his residency training at Group Health Cooperative in Seattle and completed a fellowship at the University of Washington. Dr. McAfee has been a principal investigator and co-investigator on numerous research studies focusing on questions related to the effectiveness and dissemination of telephone- and Web-based tobacco cessation programs in medical systems and through government-sponsored quitlines. He helped found and served on the Board of Directors of the North American Quitline Consortium as well as numerous state and national tobacco policy advisory groups. He also authored the World Health Organization’s quitline manual for low- and middle-income countries.
This white paper explores how public and private bodies in the UK could work together to accelerate the development and adoption of personalized medicine through strategic alliances. Personalized medicine involves classifying individuals into disease subpopulations to identify who will benefit most from specific treatments. The paper recommends that the UK focus on personalized medicine approaches for several diseases areas, and establish partnerships and initiatives to advance the necessary biomarkers and technologies.
1) SSPs prevent the spread of HIV and hepatitis C by providing clean syringes and linking drug users to medical services, saving millions in treatment costs.
2) They serve as bridges to drug treatment programs and have been shown to increase employment and access to healthcare.
3) However, the current federal ban on funding undermines local public health efforts and prevents communities from using evidence-based approaches tailored to local needs.
Effective Strategies For Intervening With Drug Abusing Offenderslakatos
This document discusses the relationship between substance abuse and criminal offending. It finds that substance abuse is highly prevalent among correctional populations, with approximately 80% of inmates meeting criteria for substance involvement. The document reviews past public safety and public health strategies for intervening with drug-abusing offenders, finding that only integrated public health/public safety programs that combine treatment and criminal justice supervision have consistently reduced recidivism and drug use. It concludes by examining Proposition 36 and other policy initiatives, arguing they should be informed by empirical lessons from prior research.
This document discusses the role of different types of evidence in informing public health policy and actions related to obesity. It makes three key points:
1. Public health aims to understand population-level causes of disease and take actions to reduce disease burden. Epidemiology provides essential evidence but considers different types of evidence.
2. Descriptive epidemiology provides difference-making evidence about risks and populations affected, which informs targets for public health actions. Mechanistic evidence from analytic epidemiology provides insights into causal pathways and how diseases work.
3. A causally-based approach to public health recognizes that different evidence serves different roles - difference-making evidence identifies what works for whom, while mechanistic evidence provides insights into potential
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
More Related Content
Similar to Fogarty-Australian television news coverage of alcohol_.pdf
The document discusses the health promotion activity of encouraging smoking cessation. It assesses the health needs, outlines the target group as smokers, and chooses an educational approach to provide information about the benefits of quitting smoking. The aims are to increase awareness of benefits, diseases caused by smoking, and where to get help. Process evaluation determined the information provided addressed different learning styles and was effective at engaging the target group.
Major tobacco-related-events-in-the-united-statesGeorgi Daskalov
This document provides a summary of major tobacco-related events in the United States from World War II to the 1980s. It outlines key milestones such as the first studies linking smoking to cancer in the 1950s, the 1964 Surgeon General's report that concluded smoking causes disease, restrictions on tobacco advertising and the introduction of warning labels on cigarette packs. It also discusses tobacco industry efforts to downplay health risks and market "safer" cigarettes while nicotine levels increased. The summary covers events that increased public awareness of tobacco's dangers and early policies to regulate tobacco use.
Reducing Tobacco Use Among Adolescents Using Social Cognitive Theory and Soci...Shauna Ayres, MPH, CHES
This document discusses reducing tobacco use among adolescents using Social Cognitive Theory (SCT) and Social Network Theory (SNT). It summarizes key aspects of SCT, including its focus on personal, behavioral, and environmental factors that influence health behaviors. Studies discussed found targeting self-efficacy, normative beliefs, and intentions through programs and policies were effective in preventing or reducing tobacco use. The document suggests using a multi-strategy approach incorporating several SCT constructs is most effective for interventions.
Analysis of alcohol industry submissions against marketing regulationBARRY STANLEY 2 fasd
The document analyzes submissions from the Australian alcohol industry in response to a review of alcohol marketing regulations. It finds that the industry's submissions were a direct lobbying tactic aimed at influencing government policy. The submissions claimed that increased regulation is unnecessary, not backed by sufficient evidence, will have unintended negative consequences, and faces legal barriers. The industry emphasized notions of regulatory redundancy and insufficient evidence more than the tobacco industry did in similar submissions. This may reflect differences in how regulated the two industries are.
The document is the proceedings from the Australian Smoking Cessation Conference in 2013. It includes:
- An introduction welcoming attendees and emphasizing the theme of translating science into clinical practice.
- An overview by the Scientific Committee of the diverse and innovative abstracts presented on topics like tailored smoking cessation methods, novel uses of nicotine replacement therapy, and programs for vulnerable groups.
- Invited speaker abstracts on topics such as integrated treatment for substance users, a smoking cessation project for pregnant smokers, smoking rates and interventions for Aboriginal people, adolescent tobacco dependence and cessation approaches.
This case study analyzes the increasing levels of lead exposure among children in Flint, Michigan due to changes in the city's water source. The authors obtained data on blood lead levels in children from Hurley Medical Center and the Michigan Department of Health and Human Services. They also collected data on the costs of treating lead exposure and Aetna's financial reports from 2010-2014. Their analysis found trends linking higher lead exposure to the Flint water source and certain demographics. Their recommendations suggest adjusting Medicaid insurance plans to better manage costs of lead treatment and strategies for Aetna to decrease financial variability and increase coverage capabilities over a five-year period.
This document summarizes the report of the House of Commons Science and Technology Committee on the UK government's alcohol consumption guidelines. It provides background on the guidelines and their history. It discusses the evidence base for the guidelines and whether it has been adequately reviewed. It also examines how well the guidelines are communicated to and understood by the public, and compares the UK guidelines to those of other countries. The report concludes that the evidence base for using purported health benefits of alcohol as a basis for daily guidelines is weak. It finds public awareness of guidelines is high but understanding is lacking. It recommends the government establish a working group to thoroughly review the evidence and advise on updating the guidelines.
This document discusses key issues and recommendations for Canada to promote at the upcoming UNGASS on drugs and UN Commission on Narcotic Drugs meeting. It recommends that Canada: 1) Promote and implement a public health approach to drugs based on evidence and human rights, including harm reduction; 2) Support harm reduction as a key component of response to drugs; 3) Pursue and support decriminalization of drug possession for personal use as essential to a public health approach. A public health approach frames drug use as a health issue and prioritizes health and human rights over punishment. Harm reduction and decriminalization are seen as necessary for an effective public health-based system.
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...Global Bridges
Presentation by Eduardo Bianco, M.D., Framework Convention Alliance, Uruguay, at the Global Bridges Preconference at the 15th World Conference on Tobacco OR Health in Singapore.
The document discusses potential policy changes regarding drug laws. It argues that current drug policies are based on fear and criminalization rather than public health. It advocates treating drug use as a public health issue and moving away from prohibition towards prevention, harm reduction, and decriminalization. Evidence from places that have implemented these approaches, like Switzerland's heroin prescription program, shows decreases in illegal drug use and drug-related crime. However, drug legalization remains poorly perceived by the public who see drugs as threatening social values and youth.
This study examined the association between tobacco control policies and smoking prevalence, denormalization of smoking, and public support for tobacco control across European Union countries. The researchers found that countries with higher scores on the Tobacco Control Scale (measuring implementation of tobacco policies) had more smokers who reported quitting due to concerns about passive smoking harming others. This concern about passive smoking was also strongly correlated with greater public support for tobacco control policies. The results suggest that addressing concerns about passive smoking is important for advancing tobacco control measures and denormalizing tobacco use in Europe.
Australia's health system needs to better connect the dots in a number of areas. Our work looks at connections between Australian chronic disease targets and indicators, WHO targets and indicators, and national progress.
CDC Update: Joining Forces to Reduce Tobacco and Cancer Among Behavioral Heal...sfary
From the the first Annual National Conference on Tobacco and Behavioral Health, which occurred May 19-20, 2014 in Bethesda, MD and was hosted by the Central East Addiction Technology Transfer Center, a program of The Danya Institute. You can see videos from the conference on our website www.ceattc.org (go to “Tobacco and Behavioral Health Resources” under “Special Topics”).
Tim McAfee, MD, MPH, is Director of CDC’s Office on Smoking and Health (OSH) within the National Center for Chronic Disease Prevention and Health Promotion. He is responsible for providing leadership and direction for all scientific, policy, and programmatic issues related to tobacco control and prevention. Before ed his residency training at Group Health Cooperative in Seattle and completed a fellowship at the University of Washington. Dr. McAfee has been a principal investigator and co-investigator on numerous research studies focusing on questions related to the effectiveness and dissemination of telephone- and Web-based tobacco cessation programs in medical systems and through government-sponsored quitlines. He helped found and served on the Board of Directors of the North American Quitline Consortium as well as numerous state and national tobacco policy advisory groups. He also authored the World Health Organization’s quitline manual for low- and middle-income countries.
This white paper explores how public and private bodies in the UK could work together to accelerate the development and adoption of personalized medicine through strategic alliances. Personalized medicine involves classifying individuals into disease subpopulations to identify who will benefit most from specific treatments. The paper recommends that the UK focus on personalized medicine approaches for several diseases areas, and establish partnerships and initiatives to advance the necessary biomarkers and technologies.
1) SSPs prevent the spread of HIV and hepatitis C by providing clean syringes and linking drug users to medical services, saving millions in treatment costs.
2) They serve as bridges to drug treatment programs and have been shown to increase employment and access to healthcare.
3) However, the current federal ban on funding undermines local public health efforts and prevents communities from using evidence-based approaches tailored to local needs.
Effective Strategies For Intervening With Drug Abusing Offenderslakatos
This document discusses the relationship between substance abuse and criminal offending. It finds that substance abuse is highly prevalent among correctional populations, with approximately 80% of inmates meeting criteria for substance involvement. The document reviews past public safety and public health strategies for intervening with drug-abusing offenders, finding that only integrated public health/public safety programs that combine treatment and criminal justice supervision have consistently reduced recidivism and drug use. It concludes by examining Proposition 36 and other policy initiatives, arguing they should be informed by empirical lessons from prior research.
This document discusses the role of different types of evidence in informing public health policy and actions related to obesity. It makes three key points:
1. Public health aims to understand population-level causes of disease and take actions to reduce disease burden. Epidemiology provides essential evidence but considers different types of evidence.
2. Descriptive epidemiology provides difference-making evidence about risks and populations affected, which informs targets for public health actions. Mechanistic evidence from analytic epidemiology provides insights into causal pathways and how diseases work.
3. A causally-based approach to public health recognizes that different evidence serves different roles - difference-making evidence identifies what works for whom, while mechanistic evidence provides insights into potential
Similar to Fogarty-Australian television news coverage of alcohol_.pdf (20)
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com